← Open Payments lookup

JESSICA MEISENHELDER: Open Payments

NPI 1447768502 · GOLDSBORO, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,125 in 18 payments from 8 companies in 2025. Trend: 2023 $396 · 2024 $456 · 2025 $1,125

Long term medical supply or device loan: $981Food & beverage: $144
CompanyPaymentsAmount
Novartis Pharmaceuticals Corporation10$981
Takeda Pharmaceuticals U.S.A., Inc.1$33
ARRAY BIOPHARMA INC2$30
RECORDATI_RARE_DISEASES_INC.1$18
ABBVIE INC.1$17
Astellas Pharma US Inc1$17
Incyte Corporation1$15
Cumberland Pharmaceuticals, Inc.1$14

Products named: KISQALI, NINLARO, ENJAYMO, VENCLEXTA, Vyloy, LORBRENA, PEMAZYRE, BRAFTOVI.

Industry payments across NC — which companies pay providers there.